|
Mobile version
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Push towards innovative funding methods University World News Share     Shrinking state budgets and financial shortfalls linked to the global recession are forcing universities to devise new means of raising revenue, notably through increased interaction with the private sector, according to participants at the Organization for Economic Co-operation and Development Institutional Management in Higher Education conference in Paris. The accelerating push towards public-private partnerships and other innovative funding methods was one of the principal themes during the conference. More
Cambridge Enterprise launches new solar energy company Cambridge Network Share
Cambridge Enterprise, the University of Cambridge's commercialisation office, and the Carbon Trust announced the launch of Eight19 Limited, a new solar energy company which will develop and manufacture high performance, lower cost plastic solar cells for high-growth volume markets. Spun out from the Carbon Trust's Cambridge University-TTP Advanced Photovoltaic Research Accelerator, this latest commercial phase will focus efforts on developing product prototypes, backed by a £4.5m investment from the Carbon Trust and leading international specialty chemicals company Rhodia. More Chinese Research Park incubates hope for scholarly spinoffs The Chronicle of Higher Education Share
The science park for China's leading technological university feels like a fantasy-land of entrepreneurship: gilded lounges, grand banquet rooms, a museum and movie theater on site — all packed into a set of matching skyscrapers around a central plaza that resembles New York City's Rockefeller Center. Mei Meng, the founder and director of Tsinghua Science Park, or TusPark, jokingly apologized for the luxury of the place. "People ask, should a science park be this beautiful?" he said, through a translator. It would have been more appropriate to build a series of garages, he noted, because that is more representative of the kind of innovative company he wants to see built here — a small startup that could become the next Apple or Microsoft. "But because we are so close to Tsinghua University and the land cost is very high, we actually can't afford to build garages," he said with a smile. "That's why we can only afford to build nice tall buildings like this." More The University of Texas at Austin recruits new chief to boost its commercialization efforts Austin American Statesman Share
Richard Miller, who founded a string of biotechnology companies in California, has taken a new job: leading the effort to commercialize technology discoveries at the University of Texas at Austin. The 59-year-old Miller is taking on the newly created position of chief commercialization officer with the task of boosting the University of Texas at Austin's success rate at turning research lab discoveries into new companies, jobs and royalty income. More Creation of nanotechnology innovation and commercialization excelerator in upstate New York Nanowerk News Share
A partnership between Lockheed Martin, the College of Nanoscale Science and Engineering of the University at Albany in New York, and the CenterState Corporation for Economic Opportunity, the $250 million Nanotechnology Innovation and Commercialization Excelerator initiative will enable the creation of 250 new high-tech jobs and position the region to become a leader in the nanotechnology industry by building on the growing cluster of nanoscale education, research and development, and commercialization assets in upstate New York. More
Federal help is necessary to keep bioscience research going The Kansas City Star Share
The Bioscience and Technology Business Center at the University of Kansas is now open for business in Lawrence, ready to serve as an incubator for startup companies and research collaborations. Through a unique partnership between the Lawrence-Douglas County Bioscience Authority, the University of Kansas, the city of Lawrence, Douglas County, the Kansas Bioscience Authority, the University of Kansas Endowment and the Lawrence Chamber of Commerce, the center will enable discoveries to make the leap from a university laboratory to the marketplace. The incubator will help create jobs and economic growth, adding to the 17 start-up companies already active in Kansas thanks to research at the University of Kansas. More University of Queensland, Australia, innovation licensed to global biopharmaceutical company NewsMaker Share
A new cancer vaccine concept developed by researchers at The University of Queensland's Diamantina Institute in Australia has been licensed to U.S.-based developer of RNAi (ribonucleic acid interference) therapeutics, Alnylam Pharmaceuticals, Inc., through UniQuest, The University of Queensland's main research commercialisation company. The University of Queensland's Diamantina Institute, specialising in cancer and immunology, is at the cutting edge of RNAi research: a natural biological process of gene "silencing." The intellectual property licensed exclusively to Alnylam relates to research from Associate Professor Nigel McMillan's molecular virology group, which was described in a paper published in the Proceedings of the National Academy of Sciences. The work investigated the use of RNAi to induce an effective immune response against tumours. More US Patent Office issues MultiStat(R) patent for treatment of rosacea GlobeNewswire via Market Watch Share
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the health care and consumer markets, announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,795,302 entitled "Use of Compositions for Treating Rosacea." The patent is part of a portfolio that Quick-Med has licensed from the University of Michigan and extends the growing intellectual property coverage of the Company's MultiStat(R) family of compounds. The patent issued covers methods for treating rosacea with an antimicrobial, a retinoid, and an inhibitor of toll-like receptors in both topical and oral applications. The broad range of antimicrobials to be utilized in combination with the MultiStat family includes tetracycline, erythromycin, azithromycin, clarithromycin, milbemycin, aminoglycoside, penicillin (optimally in combination with a beta-lactamase inhibitor), cephalosporin, fluoroquinolone, streptogramin and sulfanomide. More Michigan State University intent on mining on-campus research to turn ideas into patents, local startups Lansing State Journal Share
At one time, Michigan State University had just one man in charge of dealing with intellectual property from school researchers. But the idea of helping researchers transfer their ideas, inventions and patents to the private sector has slowly grown and evolved — from startups such as Dr. Zachary Huang's MiteZapper LLC that protects honey bee colonies, to Draths Corp., which creates chemicals from renewable materials for use in plastic bottles and other products, to larger global companies such as Lansing-based animal and food safety company Neogen Corp. Now, Michigan State University is in the midst of transforming the way it markets and develops these so-called research assets. More University of Texas ranks No. 3 in US for patent strength Austin Business Journal Share
The University of Texas System was ranked the world's third-strongest producer of patents among higher education operations, a national trade publication said. The University of Texas System climbed two spots from 2009 on Intellectual Property Today’s annual "Patent Scorecard" for universities. The University of Texas was one of 132 from the United States, Japan, Taiwan and Switzerland included in the listing. The publication ranked the universities using 2009 and 2010 data on the relative strength of each group's patent portfolio, looking at both quality and quantity. More |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
